JP2013531993A5 - - Google Patents

Download PDF

Info

Publication number
JP2013531993A5
JP2013531993A5 JP2013515568A JP2013515568A JP2013531993A5 JP 2013531993 A5 JP2013531993 A5 JP 2013531993A5 JP 2013515568 A JP2013515568 A JP 2013515568A JP 2013515568 A JP2013515568 A JP 2013515568A JP 2013531993 A5 JP2013531993 A5 JP 2013531993A5
Authority
JP
Japan
Prior art keywords
antibody
fragment
seq
influenza
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013515568A
Other languages
English (en)
Japanese (ja)
Other versions
JP6050747B2 (ja
JP2013531993A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/040982 external-priority patent/WO2011160083A1/en
Publication of JP2013531993A publication Critical patent/JP2013531993A/ja
Publication of JP2013531993A5 publication Critical patent/JP2013531993A5/ja
Application granted granted Critical
Publication of JP6050747B2 publication Critical patent/JP6050747B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013515568A 2010-06-17 2011-06-17 インフルエンザ受動免疫化に有用な抗体 Active JP6050747B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US35597810P 2010-06-17 2010-06-17
US61/355,978 2010-06-17
US201161443103P 2011-02-15 2011-02-15
US61/443,103 2011-02-15
US201161445455P 2011-02-22 2011-02-22
US61/445,455 2011-02-22
PCT/US2011/040982 WO2011160083A1 (en) 2010-06-17 2011-06-17 Antibodies useful in passive influenza immuization

Publications (3)

Publication Number Publication Date
JP2013531993A JP2013531993A (ja) 2013-08-15
JP2013531993A5 true JP2013531993A5 (2) 2014-07-31
JP6050747B2 JP6050747B2 (ja) 2016-12-21

Family

ID=45348575

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013515568A Active JP6050747B2 (ja) 2010-06-17 2011-06-17 インフルエンザ受動免疫化に有用な抗体

Country Status (12)

Country Link
US (1) US10676520B2 (2)
EP (1) EP2582721B1 (2)
JP (1) JP6050747B2 (2)
KR (1) KR101849738B1 (2)
CN (2) CN103209994B (2)
AU (2) AU2011268072C1 (2)
BR (1) BR112012032185A2 (2)
CA (1) CA2839421C (2)
DK (1) DK2582721T3 (2)
ES (1) ES2687706T3 (2)
RU (1) RU2635999C2 (2)
WO (1) WO2011160083A1 (2)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2686526T3 (es) 2011-12-05 2018-10-18 Trellis Bioscience, Llc Anticuerpos útiles en la inmunización pasiva contra la influenza
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
SG10201700488QA (en) 2012-11-13 2017-02-27 Genentech Inc Anti-hemagglutinin antibodies and methods of use
US11827693B2 (en) 2013-03-14 2023-11-28 Contrafect Corporation Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy
US10639370B2 (en) * 2014-02-04 2020-05-05 Contrafect Corporation Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
JP6712428B2 (ja) 2014-02-04 2020-06-24 コントラフェクト コーポレイション インフルエンザ受動免疫に有用な抗体ならびにその使用のための組成物、組合せおよび方法
EP3119802B1 (en) * 2014-03-20 2019-12-04 InflaRx GmbH Inhibitors of c5a for the treatment of viral pneumonia
TWI702229B (zh) 2014-12-19 2020-08-21 美商再生元醫藥公司 流行性感冒病毒血球凝集素之人類抗體
WO2017083627A1 (en) 2015-11-13 2017-05-18 Visterra, Inc. Compositions and methods for treating and preventing influenza
CN109195629A (zh) 2016-02-24 2019-01-11 威特拉公司 流行性感冒抗体分子制剂
RU2019102746A (ru) * 2016-07-14 2020-08-14 Биоарктик Аб Белок для транспорта в мозг
EP3731862A1 (en) * 2017-12-29 2020-11-04 Development Center for Biotechnology A universal vaccine against influenza
KR102820941B1 (ko) 2018-01-26 2025-06-16 리제너론 파마슈티칼스 인코포레이티드 인플루엔자 헤마글루티닌에 대한 인간 항체
CN113924147A (zh) 2019-03-25 2022-01-11 威特拉公司 用于治疗和预防流感的组合物和方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235708B1 (en) 1998-11-20 2001-05-22 Zymogenetics, Inc Testis-specific cystatin-like protein cystatin T
US20020006656A1 (en) 1999-12-23 2002-01-17 Holloway James L. Zcys5: a member of the cystatin superfamily
EP1532175B1 (en) 2002-03-22 2012-10-17 Aprogen, Inc. Humanized antibody and process for preparing the same
KR20050114225A (ko) 2003-03-07 2005-12-05 머크 앤드 캄파니 인코포레이티드 인플루엔자 바이러스 백신
CA2531684C (en) 2003-07-22 2014-03-11 Crucell Holland B.V. Binding molecules against sars-coronavirus and uses thereof
RU2366662C2 (ru) * 2003-07-23 2009-09-10 Фуджирибайо Инк. Моноклональное антитело к вирусу типа а гриппа и устройство для иммунного анализа с использованием антитела
US7413868B2 (en) 2003-11-05 2008-08-19 Trellis Bioscience, Inc. Use of particulate labels in bioanalyte detection methods
EP2024393A2 (en) * 2006-05-15 2009-02-18 Sea Lane Biotechnologies,llc. Neutralizing antibodies to influenza viruses
JP5161882B2 (ja) 2006-09-07 2013-03-13 クルセル ホランド ベー ヴェー インフルエンザウイルスｈ５ｎ１を中和しうるヒト結合性分子およびその使用
NO347649B1 (no) * 2006-12-14 2024-02-12 Regeneron Pharma Humant antistoff eller antistoff fragment som spesifikt binder human deltaliknende ligand 4 (hDII4), nukleinsyremolekyl som koder for slike og vektor og vert-vektorsystemer, samt fremgangsmåte for fremstilling, sammensetning og anvendelse.
EP3524619A1 (en) * 2007-12-06 2019-08-14 Dana-Farber Cancer Institute, Inc. Antibodies against influenza virus and methods of use thereof
WO2009121004A2 (en) * 2008-03-28 2009-10-01 Sea Lane Biotechnologies, Llc Neutralizing molecules to viral antigens
WO2010010467A2 (en) * 2008-07-25 2010-01-28 Institute For Research In Biomedicine Neutralizing anti-influenza a virus antibodies and uses thereof
TW201019959A (en) 2008-08-19 2010-06-01 Regeneron Pharma Human antibodies to human RANKL
WO2010074656A1 (en) 2008-12-24 2010-07-01 Temasek Life Sciences Laboratory Limited Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza a viruses and uses thereof
WO2011117848A1 (en) 2010-03-26 2011-09-29 Pomona Ricerca S.R.L. Full-length immunoglobulins of the igg isotvpe capable of recognizing a heterosubtvpe neutralizing epitope on the hemagglutinin stem region and their use as anti-influenza medicament
WO2012021786A2 (en) * 2010-08-12 2012-02-16 Theraclone Sciences, Inc. Anti-hemagglutinin antibody compositions and methods of use thereof
WO2012045001A2 (en) 2010-09-30 2012-04-05 Vanderbilt University Influenza virus antibodies and immunogens and uses therefor

Similar Documents

Publication Publication Date Title
JP2013531993A5 (2)
AU2021245146B2 (en) Influenza A virus specific antibodies
CN104892753B (zh) 一种中和人感染h7n9甲型流感病毒的抗体及其用途
Lee et al. Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies
RU2013102073A (ru) Антитела, подходящие для пассивной иммунизации против гриппа
HRP20201975T1 (hr) Neutralizirajuća protutijela anti-influenca a virusa i njihova uporaba
JP6371222B2 (ja) インフルエンザの受動免疫用抗体
JP2011528901A5 (2)
HRP20161740T1 (hr) Ljudske molekule za vezanje koje su sposobne neutralizirati viruse influence a filogenetske skupine 1 i filogenetske skupine 2, te viruse influence b
JP2010521147A5 (2)
JP2014237714A5 (2)
JP2016503413A5 (2)
JP2010502207A5 (2)
JP2011528902A5 (2)
JP2015522252A5 (2)
JP2012526839A5 (2)
JP2013501807A5 (2)
CN105985433B (zh) 针对h7n9亚型禽流感病毒的全人源单克隆抗体及应用
CN111094335A (zh) 广泛中和的抗流感单克隆抗体及其用途
CN101993492B (zh) 抗H5N1型高致病性禽流感scFv抗体及其应用
CN107216387B (zh) 一种b型流感病毒广谱中和抗体、其制备方法及应用
Wu et al. Allosteric Neutralization by Human H7N9 Antibodies
Jia et al. Allosteric Neutralization by Human H7N9 Antibodies
Voronina et al. Cross-reactive single-domain antibodies to hemagglutinin stem region protect mice from group 1 influenza A virus infection
Wyrzucki et al. Characterization of Influenza A-neutralizing, Heterosubtypic Antibodies Isolated with a Newly Developed Antigen